ChromaDex Corporation (CDXC) earnings
CDXC earnings moved a median of -1.15% by the close. Quarterly and annual CDXC reports and results, each read against the price at its own news timestamp. Back to the CDXC overview →
16 measured CDXC earnings events.
Where these CDXC earnings landedvs 15 measured CDXC earnings reactions
| Middle 50% of CDXC earnings reactions | -2.49% to +4.74% |
|---|---|
| Median reaction (to close) | -1.15% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 CDXC earnings events with a measured close landed between -2.49% and +4.74%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Niagen Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K ChromaDex Corp. For: Dec 31 | SEC filing · Form 10-K | +12.08% | +27.42% | |
| ChromaDex Corporation Reports Third Quarter 2024 Financial Results | Press release | +2.83% | +42.93% | |
| Form 10-Q ChromaDex Corp. For: Sep 30 | SEC filing · Form 10-Q | +2.83% | +42.93% | |
| ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 | Press release | +1.43% | +4.56% | |
| ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 | Press release | +0.00% | -1.15% | |
| ChromaDex Corporation Reports Second Quarter 2024 Financial Results | Press release | -7.12% | -2.37% | |
| Form 10-Q ChromaDex Corp. For: Jun 30 | SEC filing · Form 10-Q | -7.12% | -2.37% | |
| ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 | Press release | -1.64% | +4.92% | |
| ChromaDex Corporation Reports First Quarter 2024 Financial Results | Press release | +5.26% | -2.49% | |
| Form 10-Q ChromaDex Corp. For: Mar 31 | SEC filing · Form 10-Q | +5.26% | -2.49% | |
| ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 | Press release | +1.75% | -0.88% | |
| ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024 | Press release | -0.17% | -2.56% | |
| ChromaDex Corporation Reports Third Quarter 2023 Financial Results | Press release | -2.94% | -11.25% | |
| Form 10-Q ChromaDex Corp. For: Sep 30 | SEC filing · Form 10-Q | -2.94% | -11.25% | |
| ChromaDex to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 | Press release | -0.76% | +0.00% |
Keep exploring
More CDXC: analyst actions → · SEC filings → · CDXC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| HEMP NATURALS INC (HPMM) | 120 | 0.00% | 37% |
| Marker Therapeutics, Inc. (MRKR) | 120 | -0.23% | 39% |
| ADHERA THERAPEUTICS INC (ATRX) | 117 | 0.00% | 23% |
| MediciNova, Inc. (MNOV) | 117 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.